4D Molecular Therapeutics, Inc. financial data

Symbol
FDMT on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
5858 Horton Street #455, Emeryville, CA
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 2.35K % +30.5%
Debt-to-equity 6.83 % -37.4%
Return On Equity -24.1 % +44.5%
Return On Assets -22.5 % +42.4%
Operating Margin -649 % +87.4%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 49.8M shares +49.8%
Common Stock, Shares, Outstanding 51.9M shares +23.6%
Entity Public Float 630M USD +329%
Common Stock, Value, Issued 5K USD +25%
Weighted Average Number of Shares Outstanding, Basic 55.3M shares +44.2%
Weighted Average Number of Shares Outstanding, Diluted 55.3M shares +44.2%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 20.5M USD +826%
Revenue from Contract with Customer, Excluding Assessed Tax 20.5M USD +826%
General and Administrative Expense 40.6M USD +22%
Operating Income (Loss) -131M USD -11.7%
Nonoperating Income (Expense) 21.3M USD +250%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -110M USD +1.32%
Earnings Per Share, Basic -2.22 USD/shares +32.3%
Earnings Per Share, Diluted -2.22 USD/shares +32.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 189M USD -20%
Marketable Securities, Current 353M USD +377%
Accounts Receivable, after Allowance for Credit Loss, Current 0 USD -100%
Assets, Current 553M USD +73.9%
Property, Plant and Equipment, Net 18.8M USD -11.9%
Operating Lease, Right-of-Use Asset 10.7M USD -13.5%
Other Assets, Noncurrent 2.32M USD +115%
Assets 620M USD +75.9%
Accounts Payable, Current 3.43M USD -1.78%
Employee-related Liabilities, Current 5.49M USD +38.8%
Accrued Liabilities, Current 12.8M USD +94.3%
Contract with Customer, Liability, Current 0 USD -100%
Liabilities, Current 19.4M USD +41.1%
Contract with Customer, Liability, Noncurrent 1.32M USD +55.6%
Operating Lease, Liability, Noncurrent 10.5M USD -16.5%
Other Liabilities, Noncurrent 214K USD +792%
Liabilities 31.8M USD +16.1%
Accumulated Other Comprehensive Income (Loss), Net of Tax -293K USD -185%
Retained Earnings (Accumulated Deficit) -483M USD -29.5%
Stockholders' Equity Attributable to Parent 588M USD +80.9%
Liabilities and Equity 620M USD +75.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -29.1M USD -4.24%
Net Cash Provided by (Used in) Financing Activities 319M USD +2800%
Net Cash Provided by (Used in) Investing Activities -263M USD -710%
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 51.9M shares +23.6%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 26.5M USD +1.02%
Deferred Tax Assets, Valuation Allowance 118M USD +44.3%
Deferred Tax Assets, Gross 123M USD +41.6%
Operating Lease, Liability 13.7M USD -12.6%
Depreciation 4.7M USD +30.6%
Payments to Acquire Property, Plant, and Equipment 710K USD -29.8%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -111M USD -1.22%
Lessee, Operating Lease, Liability, to be Paid 16.7M USD -15.7%
Property, Plant and Equipment, Gross 33.1M USD +6.2%
Operating Lease, Liability, Current 3.2M USD +3%
Lessee, Operating Lease, Liability, to be Paid, Year Two 3.14M USD -3.36%
Lessee, Operating Lease, Liability, to be Paid, Year One 3.24M USD +3.02%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 3M USD -27.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.81M USD -10.4%
Deferred Tax Assets, Operating Loss Carryforwards 59.5M USD +26.6%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 11.9M USD +43.9%
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.89M USD +2.99%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 22.5M USD +24.7%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%